IN THE NEWSMariMed Inc: U.S. Pot Stock Up 135% in 2021 But Still Undervalued

May 28, 2021by MariMed Team
https://marimedinc.com/wp-content/uploads/2021/05/Untitled-design-2021-05-28T113530.425-1280x720.jpg

This article originally appeared in Profit Confidentialto see full article click here.

MariMed Stock Bullish on Record Q1 Results

Multistate operator MariMed Inc (OTCMKTS:MRMD) is one of the most compelling, undervalued cannabis stocks out there. And for good reason. MRMD stock has been on a tear since the company reported great third-quarter results in November 2020. And that stellar momentum has carried into 2021.

As of this writing, MariMed stock is up by:

  • 423% year-over-year
  • 135% year-to-date
  • 215 over the last six months
  • 215% over the last three months
  • 31% over the last five trading days.

Despite these eye-watering gains, MRMD stock still has a lot of room to run over the coming quarters and years—especially once recreational marijuana becomes legal at the federal level.

….. continued in full article at Profit Confidential 

 

Copyright © 2021 MariMed Inc. All rights reserved.